Oregon Scraps Closed-Formulary Plan But Seeks To Deny Accelerated Approval Drugs

By John Wilkerson / February 24, 2022 at 5:40 PM

Oregon is withdrawing its request for a closed drug formulary in the face of opposition from the drug industry and patient groups, but state Medicaid officials are still asking for permission to exclude accelerated approval drugs from its formularies until drug makers complete post-market studies, according to the state’s broader request that CMS waive certain Medicaid requirements.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.